José Luis Subiza (J L Subiza)

Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 14

Top Venues

Vaccines

Allergy

Cells

American journal of respiratory and critical care medicine

INMUNOTEK

Universidad Complutense de Madrid (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

INMUNOTEK Feb 01 2017

Spain

CEO

Hospital Clinico San Carlos Mar 01 1984 - Jan 31 2017

Spain

Head of Department :: Immunology

Education History

Universidad Complutense de Madrid

Spain

PHD :: Immunology

Publications

Karla Montalbán-Hernández, Ana Cogollo-García, Patricia Girón de Velasco-Sada, Raquel Caballero, Miguel Casanovas, José Luis Subiza, Laura Conejero
MV130 in the Prevention of Recurrent Respiratory Tract Infections: A Retrospective Real-World Study in Children and Adults. Vaccines 12 (2) (2024)
Karla Montalbán-Hernández, Ana Cogollo-García, Patricia Girón de Velasco-Sada, Raquel Caballero, Miguel Casanovas, José Luis Subiza, Laura Conejero
MV130 in the Prevention of Recurrent Respiratory Tract Infections: A Retrospective Real-World Study in Children and Adults. Vaccines 12 (2) (2024)
Paula Saz-Leal, Marianne Morris Ligon, Carmen María Diez-Rivero, Diego García-Ayuso, Soumitra Mohanty, Marcos Viñuela, Irene Real-Arévalo, Laura Conejero, Annelie Brauner, José Luis Subiza, Indira Uppugunduri Mysorekar
MV140 Mucosal Vaccine Induces Targeted Immune Response for Enhanced Clearance of Uropathogenic E. coli in Experimental Urinary Tract Infection. Vaccines 12 (5) (2024)
Beatriz Amorós-Pérez, Benigno Rivas-Pardo, Manuel Gómez Del Moral, José Luis Subiza, Eduardo Martínez-Naves
State of the Art in CAR-T Cell Therapy for Solid Tumors: Is There a Sweeter Future? Cells 13 (9) (2024)
Paula Saz-Leal, Marianne Morris Ligon, Carmen María Diez-Rivero, Diego García-Ayuso, Soumitra Mohanty, Marcos Viñuela, Irene Real-Arévalo, Laura Conejero, Annelie Brauner, José Luis Subiza, Indira Uppugunduri Mysorekar
MV140 Mucosal Vaccine Induces Targeted Immune Response for Enhanced Clearance of Uropathogenic E. coli in Experimental Urinary Tract Infection. Vaccines 12 (5) (2024)
Beatriz Amorós-Pérez, Benigno Rivas-Pardo, Manuel Gómez Del Moral, José Luis Subiza, Eduardo Martínez-Naves
State of the Art in CAR-T Cell Therapy for Solid Tumors: Is There a Sweeter Future? Cells 13 (9) (2024)
Paula Saz-Leal, Marianne Morris Ligon, Carmen María Diez-Rivero, Diego García-Ayuso, Soumitra Mohanty, Marcos Viñuela, Irene Real-Arévalo, Laura Conejero, Annelie Brauner, José Luis Subiza, Indira Uppugunduri Mysorekar
MV140 Mucosal Vaccine Induces Targeted Immune Response for Enhanced Clearance of Uropathogenic E. coli in Experimental Urinary Tract Infection. Vaccines 12 (5) (2024)
Beatriz Amorós-Pérez, Benigno Rivas-Pardo, Manuel Gómez Del Moral, José Luis Subiza, Eduardo Martínez-Naves
State of the Art in CAR-T Cell Therapy for Solid Tumors: Is There a Sweeter Future? Cells 13 (9) (2024)
Paula Saz-Leal, Marianne Morris Ligon, Carmen María Diez-Rivero, Diego García-Ayuso, Soumitra Mohanty, Marcos Viñuela, Irene Real-Arévalo, Laura Conejero, Annelie Brauner, José Luis Subiza, Indira Uppugunduri Mysorekar
MV140 Mucosal Vaccine Induces Targeted Immune Response for Enhanced Clearance of Uropathogenic E. coli in Experimental Urinary Tract Infection. Vaccines 12 (5) (2024)
Ralph Mosges, Christoph Zeyen, Esther Raskopf, Cengizhan Acikel, Hacer Sahin, Silke Allekotte, Mandy Cuevas, M H Mohamed Shamji, José Luis Subiza, Miguel Casanovas
A randomized, double-blind, placebo-controlled trial with mannan-conjugated birch pollen allergoids. Allergy (2023)
Antonio Nieto García, Ángel Mazón Ramos, María Nieto, Ethel Ibáñez, Dah Tay Jang, Susana Calaforra, Pilar Alba, Carmen Pérez-Francés, Ruth Llusar, Javier Montoro, Antonio de Mateo, Remedios Alamar, David El-Qutob, Francisco Javier Fernández Sánchez, Luis Moral, Teresa Toral, Mónica Antón, Carmen Andreu, Ángel Ferrer, Isabel-María Flores, Neus Cerdá, Sandra Del Pozo, Raquel Caballero, José Luis Subiza, Miguel Casanovas
First-in-human phase 2 trial with mite allergoids coupled to mannan in subcutaneous and sublingual immunotherapy. Allergy 77 (10) (2022)
Antonio Nieto García, Ángel Mazón Ramos, María Nieto, Rafael Calderón, Susana Calaforra, Blanca Selva, Sonia Uixera, Maria José Palao, Paola Brandi, Laura Conejero, Paula Saz-Leal, Cristina Fernández-Pérez, David Sancho, José Luis Subiza, Miguel Casanovas
Bacterial Mucosal Immunotherapy with MV130 Prevents Recurrent Wheezing in Children: A Randomized, Double-Blind, Placebo-controlled Clinical Trial. American journal of respiratory and critical care medicine 204 (4) (2021)
Cristina Benito-Villalvilla, Irene Soria, Mario Pérez-Diego, Enrique Fernandez-Caldas, José Luis Subiza, Óscar Palomares
Alum impairs tolerogenic properties induced by allergoid-mannan conjugates inhibiting mTOR and metabolic reprogramming in human DCs. Allergy 75 (3) (2019)
I Soria, J López-Relaño, M Viñuela, J-I Tudela, A Angelina, C Benito-Villalvilla, C M Díez-Rivero, B Cases, A I Manzano, Enrique Fernandez-Caldas, M Casanovas, O Palomares, José Luis Subiza
Oral myeloid cells uptake allergoids coupled to mannan driving Th1/Treg responses upon sublingual delivery in mice. Allergy 73 (4) (2018)

José Luis Subiza.css-eqlu8i{font-size:small;padding-left:4px;} (J L Subiza)

Publication Activity (10 Years)

Top Topics

Top Venues

José Luis Subiza (J L Subiza)